HIGH

AvKARE Norgestimate and Ethinyl Estradiol Tablets Recall for Uniformity Issue (2025)

AvKARE recalled 2,192 cartons of Norgestimate and Ethinyl Estradiol tablets distributed nationwide. The recall cites failed content uniformity specifications. Consumers and healthcare providers should stop using this medicine immediately and contact AvKARE or a healthcare provider for guidance.

Quick Facts at a Glance

Recall Date
September 2, 2025
Hazard Level
HIGH
Brand
AvKARE
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Failed Content Uniformity Specifications

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact AvKARE or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

This medicine is a combined oral contraceptive used to prevent pregnancy. It combines estrogen and progestin and is available by prescription only.

Why This Is Dangerous

The failure of content uniformity means tablets may not contain the correct amount of active ingredients, potentially leading to ineffective contraception or unintended pregnancy.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Consumers may experience reduced efficacy or unanticipated pregnancy risk. The recall affects a relatively small number of cartons but requires immediate action from users and healthcare providers.

Practical Guidance

How to identify if yours is affected

  1. Check carton NDC 42291-565-84
  2. Check blister NDC 42291-565-28
  3. Verify Lot LF41138A
  4. Confirm expiration 2027-06-30

Where to find product info

Packaging on carton and blister contains NDCs, lot number, and expiry date

What timeline to expect

Remedy processing timelines are not specified; expect guidance by mail and provider consultation within weeks

If the manufacturer is unresponsive

  • Contact your pharmacist or healthcare provider for alternatives
  • Refer to FDA recall page for updates
  • File a consumer complaint if needed

How to prevent similar issues

  • Inspect NDC codes when purchasing prescription pills
  • Verify lot and expiry before use
  • Consult a healthcare provider for alternatives if indicated by a recall

Documentation advice

Keep packaging, take photos of the lot and NDC codes, document health concerns and communications with AvKARE or a clinician

Product Details

Product: Norgestimate and Ethinyl Estradiol Tablets, USP. Dosages: 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, 0.25 mg/0.025 mg. Packaging: 3 Units, 3x28 tablets blister cards per carton. Form: Rx only. Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84. Blister NDC: 42291-565-28. Quantity recalled: 2192 cartons. Recall date: 2025-09-02. Status: Active. Hazard: Failed Content Uniformity Specifications. Remedy: Stop using the product. Contact AvKARE or your healthcare provider for guidance. Link: FDA enforcement report D-0007-2026. Lot numbers: LF41138A. Expiration: 06/30/2027. Route

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 2192 cartons recalled
  • Lot LF41138A
  • Exp 2027-06-30
  • Carton NDC 42291-565-84
  • Blister NDC 42291-565-28
  • Rx only

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Brand
Model Numbers
LF41138A
UPC Codes
42291-565
42291-565-28
42291-565-84
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more